SynthesisJournal of general internal medicine2021

Comparative Efficacy and Safety of Ultra-Long-Acting, Long-Acting, Intermediate-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: a Systematic Review and Network Meta-Analysis.

Andrea C Tricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.